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PENILAIAN EKONOMI DAN PERLAKUAN   DARIPADA PROGRAM 
PENDIDIKAN PENGURUSAN-DIRI DIABETES DALAM KALANGAN 
PESAKIT DIABETES JENIS 2 YANG MENGHADIRI PUSAT DIABETES 
AWAM DI RIYADH, SAUDI ARABIA 
 
ABSTRAK 
 
Prevalens diabetes mellitus meningkat secara mendadak dalam kalangan populasi 
Arab Saudi sejak beberapa dekad yang lalu, yang secara tidak langsung menjadi beban 
ekonomi utama terhadap sistem penjagaan kesihatan. Justeru, objektif kajian ini adalah 
untuk menilai keberkesanan program Pendidikan Pengurusan-Diri Diabetes (Diabetes 
Self-Management Education, DSME) dalam usaha meningkatkan natijah atau keputusan  
klinikal, perlakuan penjagaan-diri dan kualiti hidup. Di samping itu, kajian ini juga 
berobjektif  melaksanakan  penilaian ekonomi DSME dalam kalangan pesakit diabetes 
jenis 2. Kajian ini dijalankan di Pusat Diabetes King Abdulaziz Hospital Universiti, 
Riyadh, Arab Saudi. Kajian ini melibatkan tiga fasa, iaitu analisis keratan rentas daripada 
pemboleh ubah atau variabel kajian, praintervensi dan pascaintervensi, dan pendidikan 
ekonomi. Data diperoleh daripada semakan semula ringkasan Skala Aktiviti Penjagaan-
Diri Diabetes (Diabetes Self-care Activities Scale, SDSCA), Skala Kecekapan-Diri 
Pengurusan Diabetes (Diabetes Management Self-efficacy Scale, DMSES), dan Ujian 
Pengetahuan Diabetes Michigan (Michigan Diabetes Knowledge Test (MDKT). EQ-5D 
digunakan bagi penilaian kualiti hidup. Min skor EQ-5D dalam kalangan pesakit diabetes 
jenis 2  adalah 0.71, min skor MDKT adalah 8.96 ± 2.1, dan purata skor atitud adalah 6.38 
 xx 
 
± 2.11. Min skor kecekapan-diri total adalah 6.97 ± 1.49 dan min skor perlakuan 
penjagaan-diri total adalah 3.64 ± 1.06. Korelasi linear menunjukkan bahawa subskala diri 
adalah peramal (predictor) yang signifikan daripada perlakuan penjagaan diri masing-
masing.  Kecekapan-diri bagi pemantauan gula darah adalah peramal  yang sangat kuat 
terhadap kawalan glisemik.  Bagi fasa intervensi, seramai 75 orang pesakit diabetes jenis  
2 terlibat sama dari  April 2012 hingga Julai 2012. Setiap pesakit menjalani susulan selama 
tiga bulan dengan pengukuhan pada bulan keenam intervensi.  Sesi bagi setiap kumpulan 
dijalankan selama lima hari berturut-turut, dengan kehadiran pesakit lelaki dan perempuan 
adalah secara berasingan. Kajian intervensi menunjukkan suatu peningkatan yang 
signifkan pada tahap HbA1 (p < 0.001) dan pengurangan dalam BMI, HDL-C, SBP dan 
DBP daripada garis dasar bagi susulan pascaintervensi. Terdapat peningkatan yang 
signifikan dalam skor kecekapan-diri total (p = 0.004) dan skor perlakuan penjagaan-diri 
(p = 0.012). Kajian semasa menunjukkan bahawa kos total yang diperlukan oleh kumpulan 
intervensi adalah Saudi Riyal (SAR) 1351.38, yang lebih rendah daripada kos bagi 
kumpulan kawalan, iaitu sebanyak SAR 1933.59 bagi setiap peserta selama enam bulan 
kajian. ICER per unit penambahbaikan dalam serum TC dan tahap LDL-C adalah 0.14 
dan 0.17 (<1.0 GDP per kapita), masing-masing. Hal ini menunjukkan bahawa program 
DSME adalah suatu kaedah berkesan-kos bagi menambah baik  tahap TC dan LDL-C dari 
perspektif penyedia penjagaan kesihatan adalah berkesan-kos jika dilaksanakan di Arab 
Saudi.  
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ECONOMIC AND BEHAVIOURAL ASSESSMENT OF A DIABETES SELF-
MANAGEMENT EDUCATION PROGRAMME AMONG TYPE 2 DIABETES 
PATIENTS AT DIABETES CENTRE IN RIYADH, SAUDI ARABIA 
 
ABSTRACT 
 
The prevalence of diabetes mellitus has increased tremendously among the Saudi 
population during the last decade. This represent as a major economic burden in health 
care system. The objective was to evaluate the effectiveness of the Diabetes Self-
Management Education (DSME) programme in improving clinical outcomes, self-care 
behaviours and Health Related Quality of Life and to perform an economic evaluation of 
DSME on health status in type 2 diabetes patients at the Diabetic Centre in King Abdulaziz 
University Hospital, Riyadh, Saudi Arabia. The study include three phases a cross 
sectional, pre and post interventional and economic study. The data were obtained by 
using questionnaires completed during face-to-face interviews. The revised summary of 
the Diabetes Self-care Activities Scale (SDSCA), the Diabetes Management self-efficacy 
Scale (DMSES), the University of Michigan Diabetes Research and Training Centre 
(MDRTC) knowledge test and the diabetic care profile of the University of Michigan were 
used to measure attitudes towards diabetes. The Health Related Quality of Life was 
assessed at baseline using The Quality of Life scale (EQ-5D). In cross sectional descriptive 
study, the mean of EQ-5D score in type 2 diabetic patients was 0.71, which is considered 
a moderately low score. The mean score of the MDKT was 8.96 ± 2.1, indicating that 
overall, the patients had moderate knowledge about diabetes. The average attitude score 
 xxii 
 
of all respondents in this study was overall, positive of 6.38 ± 2.11. The mean scores of 
total self-efficacy were moderately low, at 6.97 ± 1.49 of 10.00 as the maximum score. 
The mean scores of the total self-care behaviours were low, at 3.64 ± 1.06 of 7.00 as the 
maximum score. Linear correlations showed that self-efficacy subscales were significant 
predictors of their respective self-care behaviours. The self-efficacy for blood sugar 
monitoring seemed to be a stronger predictor of glycaemic control. A total of 75 type 2 
diabetes patients were enrolled from April 2012 to July 2012 (over four months) as a 
baseline study and each patient was followed up for three months with reinforcement and 
at six months after intervention. Group sessions were conducted for five consecutive days 
with males and females attending separately. The interventional study revealed a 
significant improvement in HbA1c levels (p < 0.001) and reduction in BMI, HDL-C, SBP 
and DBP from baseline to post-intervention follow-up. There is also a significant increase 
in the total self-efficacy (p = 0.004) and the total self-care behaviours scores (p = 0.012). 
The present study demonstrated that the total cost incurred by the intervention group was 
Saudi Riyal (SAR) 1351.385, which was lower than the cost incurred by the control group 
(SAR 1933.596) per participant over the 6-month study period. The ICER per unit 
improvement in serum TC and LDL-C levels were 0.14 and 0.17 (<1.0 GDP per capita in 
Saudi Arabia), respectively indicating that the DSME programme as a highly cost-
effective method of improving TC and LDL-C levels from the perspective of health care 
providers that would be cost-effective if implemented in Saudi Arabia. 
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CHAPTER 1 
INTRODUCTION 
 
1.1 Background of the study  
Diabetes refers to a group of metabolic diseases characterized by chronic hyperglycaemia 
that results from defects in insulin secretion, insulin action, or both. The autoimmune 
destruction of pancreatic β-cells is one of the pathogenic processes that cause the 
development of diabetes. This disease is associated with disturbance in carbohydrate, fat 
and protein metabolism caused by the deficient insulin action on target tissues. Deficient 
insulin action results from inadequate insulin secretion (American Diabetes Association, 
2014a).  Type 2 diabetes, or non-insulin-dependent diabetes, is one of the 3 types of 
diabetes and affects 90-95% of diabetic patients (American Diabetes Association, 2014a).   
Diabetes is the most common chronic endocrine disorder, affecting around 5‒10% of the 
adult population in industrialized countries throughout the world (Wild, Roglic, Green, 
Sicree, & King, 2004). The International Diabetes Federation (IDF) has estimated that 246 
million adults had diabetes at 2007 in the seven regions of the IDF. This value had 
increased by 52 million from that of 2003, and the number is projected to increase to 380 
million by 2025 (International Diabetes Federation, 2013).   
In the Kingdom of Saudi Arabia, rapid economic growth during the last four decades and 
urbanization have led to changes in lifestyle characterized by unhealthy diets and 
diminished physical activity; accordingly, the prevalence of diabetes has continually risen 
over the last two decades, representing a major clinical and public health problem 
(Alqurashi, Aljabri, & Bokhari, 2011). In the late 1970s and early 1980s, the prevalence 
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of diabetes in Saudi Arabia was similar to that in other countries. In the last three decades, 
diabetes has become an epidemic chronic disease in Saudi Arabia (Elhadd, Al-Amoudi, & 
Alzahrani, 2007).   
Improvements in socioeconomic status and urbanization, which are related to rapid 
changes in lifestyle, diet, obesity, and physical activity, are important risk factors for 
diabetes. Accordingly, in most developing countries, the prevalence of diabetes is two-
fold higher in urban areas than in rural areas (King & Rewers, 1993). 
There are many barriers to optimal diabetic care; these include educational barriers, 
including lack of knowledge and low awareness of services. External physical barriers, 
such as poor quality of services and inappropriate diabetic care, also play a role in diabetic 
care. Psychosocial barriers include a lack of public awareness, a lack of community 
support and psychological factors such as health beliefs, poor motivation, low self-
efficacy and emotional stress (Simmons, 2001). 
Quality of Life is an important health outcome that is assessed via measures of social 
functioning and perceived physical and mental well-being (Testa & Simonson, 1996). 
Accordingly, effective health education programmes based on increasing diabetes 
awareness, promoting behavioural changes and overcoming all barriers are needed for 
optimal diabetes management, which in turn will lead to improvements in health outcomes 
and Quality of Life (Al-Shehri, Taha, Bahnassy, & Salahc, 2008). In general, the Quality 
of Life of an individual with diabetes is worse than that of a similar age person without 
diabetes, and an increase in the number of complications is associated with a poorer 
Quality of Life (Grandy & Fox, 2008; Holmes et al., 2000). 
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The economic burden of diabetes for patients and for society is tremendous. The IDF has 
reported that expenditures for diabetes care has increased, constituting 11.6% of all health 
care expenditures in 2010 (International Diabetes Federation, 2008). In the Middle East, 
the economic burden of diabetes has risen consistently with the increased prevalence of 
diabetes (Al-Maatouq et al., 2010), and the majority of diabetes-related costs are due to 
complications of the disease (Gray et al., 2000). 
Among the most important educational approaches for diabetic patients are diabetes self-
management education (DSME) programmes, which are an essential part of diabetes care 
(International Diabetes Federation, 2013). Studies have demonstrated that didactic 
approaches for educating diabetic patients should not be supported (Steed et al., 2005); 
effective education for type 2 diabetes patients has been shown to incorporate DSME 
(Rickheim, 2002). 
The AADE7TM Self-care Behaviours form the framework for diabetes education. These 
behaviours include healthy eating, physical activity, medication consumption, blood sugar 
monitoring, problem solving, reduction of chronic and acute complications and healthy 
coping; all of these behaviours are essential for successful and effective diabetic self-
management (Austin, 2006). Thus, diabetic education that focuses on these seven self-
care behaviours is important for improving health status and Quality of Life (American 
Association of Diabetes Educators, 2008). 
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1.2 Problem statement 
The prevalence of diabetes in the Saudi population has increased significantly to 
approximately 23.7%, which is one of the highest rates in the world (Al-Nozha et al., 
2004) and almost one in every 11 Saudi people had been diagnosed with diabetes. This 
prevalence is set to increase to one in five by 2020 if the current prevalence rate continues 
without change over time and there is no adoption of diabetes education programmes 
(Alhowaish, 2013); moreover, the WHO has estimated that the prevalence of diabetes in 
the Middle East will be the highest in the world by the year 2030, increasingly by 163% 
(Wild et al., 2004). In addition, the prevalence of multiple diabetic complications such as 
cardiovascular disease is extremely high, and the progression of End Stage Renal Disease 
(ESRD) is rapid. Moreover, all of these factors lead to an overwhelming economic burden 
because of the consumption of the majority of health care economic resources by diabetic 
patients (Jamal, Durdana, Al Suwaida Abdulkaraem, Nawaz, & Fathia, 2009); and patients 
with diabetes account for 2.6% of all hospital admissions and 3.5% of all hospital stays in 
Saudi Arabia. The cost of diabetes was approximately $0.9 billion of the total healthcare 
expenditure in 2010, which accounts for ten times more expenditure than for people 
without diabetes (Alhowaish, 2013).  
In the last three decades, diabetes mellitus has become an epidemic disease in Saudi Arabia 
as a consequence of the development and socio-economic transformation of the country 
during that time from a tribal and nomadic to a modern lifestyle, which in turn has led to 
changes in dietary habits and a high prevalence of obesity due to reduced physical activity 
(Azab, 2001; Elhadd et al., 2007). 
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The lack of proper diabetes education and awareness programmes in Saudi Arabia 
exacerbates gaps in knowledge and inadequacies in compliance, and  also inadequacies in 
self-management which affects glycaemic control (Saadia, Rushdi, Alsheha, Saeed, & 
Rajab, 2010; Uddin, Ahmad, Kurkuman, & Iftikhar, 2001). Because this lack of literacy 
is more prevalent among uneducated and older people (Al-Baghli, Al-Ghamdi, et al., 
2010; Midhet, Al-Mohaimeed, & Sharaf, 2010), therefore, improving knowledge of 
diabetes in will not be an easy task. 
Most diabetic patients are unaware of their disease status, which leads to poor glycaemic 
control and more complications, resulting in decreased productivity; consequently, Saudi 
Arabia has an urgent need for structured programmes to educate the public and improve 
awareness about diabetes and its complications to improve Quality of Life and control 
diabetes (Al-Nozha et al., 2004; Amer, Attia, Ahmed, & Mohammad, 2008; Azab, 2001; 
El-Hazmi, Warsy, Al-Swailem, Al-Swailem, & Sulaimani, 1998).      
 
1.3 Rationale of study  
The prevalence of diabetes in Middle East countries is much higher than that in other parts 
of the world, and it is projected to more than double by 2025 (International Diabetes 
Federation, 2013). Moreover, the WHO projects that the number of diabetic patients in 
Saudi Arabia will nearly triple from 890,000 in 2000 to 2,523,000 by 2030 (Wild et al., 
2004). Poor glycaemic control is common among the Saudi diabetic population; studies 
indicate that only 24% of patients attain the target glycaemic control, compared to 32% 
with poor glycaemic control, and only 4.5% of patients achieve glucose, blood pressure 
and LDL cholesterol control (Eledrisi et al., 2007). The dramatic increase in the incidence 
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of diabetes is related to several factors, such as advancing age. This can be seen in the 
rising proportion of sufferers according to age: 21% for people aged 30‒39 years, 23% for 
those aged 40‒49 years, 33.8% for those aged 50‒59 years and 36.5% for those aged 60‒
70 years (Al-Nozha et al., 2004). It is well established that obesity is a strong risk factor 
for the development of diabetes (Daniel, Rowley, McDermott, & O'Dea, 2002; Gordon et 
al., 1999). In the Kingdom of Saudi Arabia, obesity is increasing at a similar rate to 
diabetes (Al Nuaim, 1997; Warsy & El-Hazmi, 1999). 
It appears that urbanization and changes to the modern lifestyle have resulted in increased 
sedentary activity and consumption of high calorie foods, indicating the significance of 
these changes in the increased frequency of diabetes mellitus and hence their association 
with the expanded prevalence of micro- and macro-vascular complications (El-Hazmi et 
al., 1998; Elhadd et al., 2007). Several unhealthy dietary patterns are responsible for the 
rising incidence of diabetes, such as unhealthy items (kabsa, French fries and bakery 
items) that are commonly consumed by the Saudi population (Midhet et al., 2010). This 
pattern is consistent with the findings of a 12-year prospective study in the U.S. that 
revealed the development of diabetes  to be associated with Western dietary habits, 
including the high consumption of red meat, French fries, high-fat products and sweets 
(van Dam, Rimm, Willett, Stampfer, & Hu, 2002). 
It is well recognized that physical inactivity and sedentary living habits are major threats 
to the health of the world’s population (WHO, 2003). The prevalence of inactivity in the 
Saudi population is high and ranges from 43 to 99.5% among Saudi children and adults 
(Al-Hazzaa, 2004).  Diabetes management requires compliance and adherence, because 
non-compliance, non-adherence, poverty, lack of knowledge and low rates of follow-up 
are the main factors related to poor glycaemic control (Kalyango, Owino, & Nambuya, 
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2008); therefore, many factors, including demographic, psychological  and social aspects, 
affect compliance and adherence. Healthcare providers, treatment-related factors and the 
social support provided by the health care team are important for promoting the adherence 
of diabetic patients to their diets, medications, self-monitoring of blood glucose levels and 
physical activity (Sherbourne, Hays, Ordway, DiMatteo, & Kravitz, 1992), indicating the 
importance of the patient-doctor relationship in adherence and compliance. 
On the other hand, satisfaction is the most important factor that aligns patients with their 
doctor’s recommendation, promoting a positive outcome and ultimately termination of the 
patient-doctor relationship: diabetic patients who are more satisfied with their physician’s 
humanity and communication are more likely to be compliant and adhere to treatment and, 
consequently, have better glycaemic control (Sherbourne et al., 1992; Viinamäki, 
Niskanen, Korhonen, & Tähkä, 1993). In addition, patients’ satisfaction with their doctors 
is related to the characteristics of the patients themselves rather than those of their 
healthcare providers (Franciosi et al., 2004). 
 A study conducted in Saudi Arabia revealed that 33% of patients received satisfactory 
health education, whereas 67% received unsatisfactory care. It appears that a lack of 
literacy and education results in dissatisfaction regarding the information received and 
poor glycaemic control (Al-Khaldi & Khan, 2000), which explains the wide gap between 
effective diabetic interventions and their implementation in practice (Eledrisi et al., 2007). 
The Ministry of Health in Saudi Arabia has provided detailed guidelines for health 
education for diabetic patients, but their implementation requires further reinforcement 
(Ministry of Health, 2002). 
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Diabetes can be managed through lifestyle changes and adherence to medication; 
therefore, it is very important to adopt education programmes for diabetic patients to 
reduce the growing burden of diabetes-related morbidity and mortality. Through diabetes 
education programmes, patients can acquire knowledge and skills, develop the confidence 
needed for appropriate self-care behaviours, and learn problem-solving and coping skills 
to overcome any barriers to effective self-care. Patients can improve their ability to 
achieve effective self-care, including appropriate and effective physical activity, what and 
when to eat, how much to eat, how to reliably monitor blood glucose levels, how to use 
those results to adjust dietary habits, and appropriate exercise and treatment choices, 
which in turn enhance clinical outcomes and, consequently, improve quality of life. 
 
1.4  Conceptual Framework 
This conceptual framework will highlight the diabetes self-care behaviours that influence 
measures of outcome for DSME and determine the effectiveness of DSME programs. A 
diabetes self-management education program is a collaborative process through which 
people with diabetes gain knowledge, acquire skills, improve motivation and learn how to 
solve problems.  
The immediate objective of DSME programmes is to help diabetic patients to improve 
self-care knowledge and develop psychosocial mediators, such as attitude, self-efficacy, 
and coping skills. These immediate outcomes of knowledge and psychosocial mediators 
are not direct predictors of health per se; however, these mediators are supposed to work 
through self-care behaviours, and hence are directly linked to clinical outcomes.  
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Diabetes self-care behaviours, including a healthy diet, physical activity, medication 
consumption, blood glucose monitoring, problem solving (particularly regarding blood 
glucose high and low levels and sick days), reducing the risk of diabetic complications 
and living with diabetes (psychosocial adaptation), are primary outcomes of DSME 
programmes. Consequently, healthy eating to reduce fat intake, optimizing physical 
activity, overcoming barriers to attain glycaemic control and improving problem-solving 
skills lead to improved short-term clinical outcomes (e.g. HbA1c level blood pressure, 
body mass index (BMI), and lipid level). These improvements in clinical outcomes lead 
to improvements in health status, which in turn result in enhanced Quality of Life and 
economic benefits for people with diabetes and society (figure 1.1).  
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 Figure 1.1: Conceptual framework 
Self-care Behaviours 
1- Healthy eating 
2- Physical activity 
3- Medication taking 
4- Monitoring of blood glucose 
5- Reducing risk of complication 
6- Problem solving 
7- Living with diabetes 
Clinical outcomes (short-term) 
HbA1c, blood pressure, lipid profiles and 
BMI
Health status outcomes (long-term) 
Health Related Quality Of Life, morbidity 
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1.5  Significance of the Study 
Because of the nature of diabetes as a non-communicable chronic disease, it is difficult 
for most diabetic patients to cope with their lifestyle changes, complying with treatment 
and attaining sustainable glycaemic control. Moreover, the high prevalence of diabetes in 
Saudi Arabia due to unhealthy diets and low physical activity combined with multiple 
diabetic complications has led to an overwhelming economic burden because of the 
consumption by diabetes care of the majority of the economic resources for healthcare. 
Therefore, DSME programmes are required to help diabetic patients manage their 
condition. In addition, the cost and effectiveness of DSME programmes need to be 
compared with those of usual care. Therefore, at the end of this study, decision makers in 
the Saudi Ministry of Health will have clear findings regarding the clinical outcomes and 
benefits of this programme. 
Clinical outcome measures, such as HbA1c, blood pressure, cholesterol and BMI, will 
help the decision makers to evaluate the current status of diabetic patients and assist them 
in understanding the improvements in clinical outcome measures and health status after 
the implementation of this programme. 
On the other hand, the psychosocial outcomes in this study, such as attitude and self-
efficacy, will help physicians in general hospitals and primary healthcare clinics to help 
diabetic patients cope with barriers and solve problems to attain better glycaemic control. 
The economic evaluation of this programme will be performed via an assessment of the 
cost-effectiveness per unit improvement of glycaemic control of HbA1c. This economic 
evaluation will provide a clear view of the effectiveness of this programme and its 
potential application on a countrywide basis. 
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The American Diabetes Association (2014b) has reported that a 1% reduction in HbA1c 
levels reduces the risks of cardiovascular complications, diabetes-related death, all-cause 
mortality, and combined fatal and non-fatal myocardial infarction by 35%, 25%, 7% and 
18%, respectively. Accordingly, the Saudi Arabian Ministry of Health may wish to adopt 
the DSME programme to facilitate health gains, high Quality of Life and better glycaemic 
control, which will decrease the diabetes healthcare expenditures across all health sectors 
in Saudi Arabia.   
 
1.6 Study Objectives   
1.6.1      Main objective 
The main objective of this study is to evaluate the effectiveness of the Diabetes Self-
Management Education (DSME) programme in improving clinical outcomes, self-care 
behaviours and Health Related Quality of Life and to perform an economic evaluation of 
a diabetic self-management education programme on health status in type 2 diabetes 
patients at the Diabetic Centre in King Abdulaziz University Hospital, Riyadh, Saudi 
Arabia. 
1.6.2      Specific objectives: 
1- To evaluate the effect of DSME programmes in improving short-term outcomes, 
including HbA1c levels, blood pressure, lipid profile and body mass index (BMI), 
of patients with type 2 diabetes. 
2- To evaluate the effect of DSME programmes in improving knowledge, attitude 
and self-efficacy of patients with type 2 diabetes. 
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3- To evaluate the effects of DSME programmes in facilitating self-care behavioural 
changes after intervention in patients with type 2 diabetes. 
4- To evaluate the effects of DSME programmes in improving the Health Related 
Quality of Life of patients with type 2 diabetes. 
5-  To determine the proportion of patients with diabetes achieving improved 
glycaemic control after the completion of a DSME programme. 
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CHAPTER 2 
LITERATURE REVIEW 
 
 
2.1 Diabetes Mellitus 
2.1.1      Definition of diabetes mellitus  
Diabetes mellitus (DM) is a common disease involving a heterogeneous group of diseases 
of various aetiologies characterized by an increase in blood glucose level termed 
hyperglycaemia. The chronic hyperglycaemia of diabetes is associated with metabolic 
abnormalities of carbohydrate, fat and protein with related defects of insulin action on 
target tissue or its secretion, or both (American Diabetes Association, 2014a). DM occurs 
when the body fails to absorb glucose due to inadequate or inefficient insulin secretion. 
 
2.1.2      Classification of diabetes    
DM based on aetiology was classified into four groups according to an international expert 
committee. The classification specified four types of diabetes mellitus: type 1, type 2, 
gestational diabetes and other specific type (The Expert Committee on the Diagnosis and 
Classification of Diabetes Mellitus, 2002). 
Type 1 diabetes is associated with β-cell damage or destruction caused by an autoimmune 
destruction, resulting in reduced insulin or absolute insulin deficiency (Falorni, Kockum, 
Sanjeevi, & Lernmark, 1995; The Expert Committee on the Diagnosis and Classification 
of Diabetes Mellitus, 2002). This type of diabetes affects 5‒10% of diabetic patients 
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(American Diabetes Association, 2014a). The aetiology of the autoimmune destruction of 
type 1 diabetes is still not well defined, but the development of the disease is related to 
multiple genetic predispositions and environmental factors (Peng & Hagopian, 2006; 
Visalli et al., 2003). Over 95% of individuals with type 1 diabetes mellitus develop the 
disease before the age of 25; it can be managed with a combination of pharmacological 
and non-pharmacological treatments such as insulin, diet and exercise (Franz et al., 2004). 
In this type of diabetes, patients need exogenous administration of insulin for survival 
(American Diabetes Association, 2014b). 
While the incidence of type 1 diabetes is highest in children and adolescents, type 2 also 
affects younger adults and adolescents in addition to adults (King, 1999). Type 2 diabetes 
is associated with a family history of diabetes and is more prevalent in females, especially 
those with a history of gestational diabetes and over 40 years old. Also, the incidence of 
this type of diabetes increases in younger people with obesity and lack of physical activity 
(Alberti, Zimmet, & Shaw, 2007; American Diabetes Association, 2000; Silverstein & 
Rosenbloom, 2001). This type of diabetes encompasses individuals who have a defect in 
insulin secretion and insulin resistance; these patients do not need treatment with insulin 
for survival. Many previous studies have reported that insulin resistance usually happens 
in a pre-diabetic state that may persist for many years (American Diabetes Association, 
2014a). Type 2 diabetes is associated with a strong genetic predisposition and have a three-
fold increase risk of DM in comparison to non-diabetic people (McIntyre & Walker, 
2002). Previous studies reported that liver and skeletal muscles are the key tissues for 
insulin resistance in type 2 DM (DeFronzo, Gunnarsson, Björkman, Olsson, & Wahren, 
1985). 
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Gestational diabetes refers to glucose intolerance, which is first detected during 
pregnancy. In the 1960s, O’Sullivan found that the increase in development of diabetes 
after pregnancy was contributed to by the degree of glucose intolerance (Buchanan & 
Xiang, 2005). 14% of pregnancies in the U.S. are affected by impaired glucose tolerance 
and it is a recognized risk factor for mothers with type 2 DM (Jovanovic & Pettitt, 2001). 
Women who are obese, older than 25 years and unable to compensate for the developing 
glucose intolerance have a higher risk of developing gestational diabetes mellitus (Kjos & 
Buchanan, 1999). Women with prior GDM are associated with a higher risk for insulin 
resistance and hence are more likely to develop diabetes than a normal woman (Ryan et 
al., 1995).  
 
2.1.3      Diagnosis of diabetes  
Diabetes is defined as symptomatic or a symptomatic state of abnormalities in 
carbohydrate metabolism; the diagnosis can be made when one or more symptoms of 
diabetes are in existence and can be confirmed by a high blood glucose level in a venous 
blood sample. 
The diagnostic criteria for diabetes based on the venous blood sample and laboratory 
methods are shown in Table 1 (American Diabetes Association, 2014a): a fasting plasma 
glucose (FPG) level ≥ 7.0 mmol/L in concordance with a 2-hour plasma glucose (2hPG) 
value ≥ 11.1 mmol/L in a 75g oral glucose tolerance test (OGT) in regard to the prevalence 
of retinopathy (Engelgau et al., 1997; Ito et al., 2000; The Expert Committee on the 
Diagnosis and Classification of Diabetes Mellitus, 1997). The use of the HbA1c test for 
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diagnosis of diabetes with the threshold of ≥ 6.5% has been recommended by the 
International Expert Committee (International Expert Committee, 2009) and there is a 
relationship between the diagnostic cut-point of HbA1c, FPG and 2hPG concerning the 
prevalence of retinopathy (Colagiuri et al., 2011; International Expert Committee, 2009). 
The decision of which tests should be used for diagnosis of diabetes is contributed to by 
clinical judgement. If the patient presents with symptoms of hyperglycaemia, it is 
preferable that the same test be repeated for confirmation of diabetes. For example, HbA1c 
is 7% and the repeated result is 6.85%: thus, the diagnosis of diabetes is confirmed. 
However, if the results of two different tests (FPG and HbA1c) are both above the 
diagnostic cut-point, this also means that the diagnosis of diabetes is confirmed. On the 
other hand, when two different tests for an individual are available and the results are 
conflicting, the test whose result is above the diagnostic thresholds should be repeated, 
which is the basis of diagnosis of diabetes (Sacks, 2011).    
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Table 2.1 Criteria for the diagnosis of diabetes 
* (NGSP) National Glycohemoglobin Standardization Program, (DCCT) Diabetes 
Control and   Complications Trial reference assay. ** (FPG) fasting plasma glucose. *** 
(OGTT) oral glucose tolerance test.  
 
 
2.1.4      Clinical presentation of diabetes  
Diabetes can exhibit symptoms such as marked hyperglycaemia, polyuria, polydipsia, 
weight loss, polyphagia and blurred vision or be a symptomatic, depending on the severity 
of the metabolic abnormalities (American Diabetes Association, 2014a). Chronic 
hyperglycaemia in patients is associated with growth impairment and susceptibility to 
certain infections. Usually the initial symptoms of diabetes (polyuria, polydipsia and 
weight loss) are associated with the early diagnosis of diabetes (Ganong & Systems, 
1995).    
 
 A1C ≥ 6.5%. The test should be performed in a laboratory using a method 
that is NGSP certified and standardized to the DCCT assay*. 
OR 
 FPG ≥ 126 mg/dL (7.0 mmol/L). Fasting is defined as no caloric intake for 
at least 8 h.** 
OR  
 Two-hour PG ≥ 200 mg/dL (11.1 mmol/L) during an OGTT. The test should 
be performed as described by the WHO, using a glucose load containing the 
equivalent of 75 g anhydrous glucose dissolved in water.*** 
OR 
 In a patient with classic symptoms of hyperglycaemia or hyperglycaemic 
crisis, a random plasma glucose ≥ 200 mg/dL (11.1 mmol/L). 
 In the absence of unequivocal hyperglycaemia, result should be confirmed 
by repeat testing. 
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2.1.5      Diabetes complications 
Long-term diabetes is associated with microvascular complications, such as retinopathy 
and neuropathy, and macrovascular complications, such as myocardial infarction, angina 
pectoris and stroke (Grandy & Fox, 2008; Hamadeh, 2000). An epidemiological analysis 
of the United Kingdom Prospective Diabetes Study (UKPDS) data revealed a continuous 
relationship between hyperglycaemia and the above microvascular complications (UK 
Prospective Diabetes Study (UKPDS) Group, 1998). People with type 2 diabetes have a 
two- to four-fold higher risk of coronary heart disease, peripheral vascular disease and 
stroke than the general population, and these account for approximately 65% of diabetes 
mortality. In 2006, diabetes was classified as the seventh leading cause of death in the U.S. 
(Al-Ajlan, 2007; Dall et al., 2008). 
 
2.1.6      Glycosylated haemoglobin  
The fasting plasma glucose (FPG) test and the oral glucose tolerance (OGT) test are the 
most widely used screening tests for measurement of blood glucose. However, both FPG 
and OGT require the patient to fast for eight hours overnight and diagnosis by FPG 
requires the test to be performed at least twice to confirm the diagnosis. In addition, 
diagnosis by FPG is not sensitive, since diabetes remains undetected in one third of 
sufferers (Barr, Nathan, Meigs, & Singer, 2002). It has been suggested that the 
glycosylated haemoglobin (HbA1c) test be used as alternative test for type 2 diabetes. It 
is important that individuals with diabetes know and understand their level of HbA1c. It 
has been used as the gold standard for the level of mean glycaemic control, representing 
the percentage of blood glucose that has reacted with a person’s haemoglobin. HbA1c can 
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assess the average blood sugar over two to three months because red blood cells live for 
that time period (American Diabetes Association, 2014b).  
HbA1c is widely accepted as an important marker for assessing chronic hyperglycaemia 
and should be measured every three to six months to estimate blood glucose after a 
medication treatment regimen (American Diabetes Association, 2014b; Goldstein et al., 
2004; Saudek, Derr, & Kalyani, 2006). Many studies report that there is a relationship 
between HbA1c and the risk for complications in epidemiological studies and clinical 
trials in both type 1 (Diabetes Control Complications Trial Research Group, 1995) and 
type 2 (Stratton et al., 2000). This has helped to establish a widely accepted HbA1c target 
for diabetes care to delay and prevent the development of different of long-term 
complications (American Diabetes Association, 2014b; European Diabetes Policy, 1999; 
Nathan et al., 2006).   
Moreover, many previous epidemiological studies reported that patients with level of 
HbA1c ≥ 7% are associated with significantly high risk of microvascular and 
macrovascular complications (Diabetes Control Complications Trial Research Group, 
1995; Stratton et al., 2000; Turner, Holman, et al., 1998). It has been suggested that HbA1c 
level above the diagnostic threshold for diabetes (6.0% to < 6.5% ) is correlated with high 
risk  for incidence of diabetes (International Expert Committee, 2009) and people with the 
same this range of HbA1c  have 10 times more progression of diabetes than those people 
with low level of HbA1c (Edelman, Olsen, Dudley, Harris, & Oddone, 2004; Pradhan, 
Rifai, Buring, & Ridker, 2007; Shimazaki, Kadowaki, Ohyama, Ohe, & Kubota, 2007). 
Preventive interventions program should be initiated for individuals whose HbA1c values 
in the range of 5.5% - 6.0% (Knowler et al., 2002; Tuomilehto et al., 2001). 
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On the other hand, each 1% reduction in HbA1c value is associated with a 37% decrease 
in the risk of microvascular complications and a 14% decrease in myocardial infarction, 
as well as fewer deaths related to DM. The Diabetes Control and Complications Trial 
Research Group (1995) reported that there is a relationship between HbA1c and plasma 
glucose (PG), since 6% of HbA1c corresponded to a 135 mg/dl (7.5 mmol/L) level of 
mean plasma glucose. Furthermore, each 1% increase in HbA1c corresponded to a 35 
mg/dl (2 mmol/L) increase in mean plasma glucose, and this can help the healthcare 
providers and their patients with diabetes to adjust targets level of plasma glucose on a 
day-to-day basis in order to achieve the optimal specific HbA1c goals (Rohlfing et al., 
2002).    
 
2.1.7      Glycaemic control  
Optimal glycaemic control is significant to the management of diabetes. Several clinical 
trials have reported that improved glycaemic control is associated with a reduction in the 
microvascular complications of diabetes in both type 1 and type 2 (Stratton et al., 2000; 
The Diabetes Control Complications Trial Research Group, 1993; UK Prospective 
Diabetes Study (UKPDS) Group, 1998). 
A cross-sectional PANORAMA study of type 2 diabetes was conducted in nine countries 
(Belgium, France, Germany, Greece, Italy, the Netherlands, Spain, Turkey and the UK) 
>1 year prior to study entry. In this study, a total of 5817 European patients and 397 
physicians were randomly enrolled or consecutively selected from physician’s practices 
between May 2009 and April 2010. The study aimed to examine the number of patients in 
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those countries who were not achieving the optimal goal of glycaemic control and to 
evaluate the association between glycaemic control and demographic, clinical and 
treatment factors. The findings of the PANORAMA study showed that the mean HbA1c 
of the total patient population was 6.9% and 37.4% of the patients had HbA1c ≥ 7%. The 
study found that those who were younger, female, unemployed, less educated and with a 
longer duration of diabetes were more likely to have suboptimal glycaemic control. 
Furthermore, a multivariate analysis revealed that treatment by a combination of therapy, 
an oral glycaemic agent and insulin were significant predictors of poor glycaemic control 
(de Pablos-Velasco et al., 2014). 
In Malaysia, the Ministry of Health in Hulu Langat, Selangor, conducted a cross-sectional 
survey over a seven-month period in seven primary health clinics. The data were collected 
as a systematic random sample of a total of 557 type 2 diabetic patients who participated 
in the study. This study was carried out to determine the glycaemic control status and 
factors, which are, associated with good glycaemic control of type 2 diabetic patients. The 
study found that the average age of the participants was 56 years, with an average duration 
of disease of 7.8 years. The mean HbA1c level for all 557 patients was 8.04%. Patients 
who were receiving an oral hypoglycaemic agent had better glycaemic control than those 
who were receiving a combination of insulin and an oral hypoglycaemic agent. Finally, 
this study concluded that older patients, shorter duration of disease, mono-therapy and 
good adherence to the treatment were found to be significantly associated with good 
glycaemic control, and healthcare providers in the Ministry of Health in Malaysia should 
advise patients to reduce their sugar intake, eat healthy food and adhere to their medication 
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treatment in order to attain better glycaemic control (Ahmad, Islahudin, & Paraidathathu, 
2013). 
In Saudi Arabia, a cross-sectional study was conducted in diabetic patients visiting King 
Khalid University Hospital, Riyadh. A total of 1520 participants who were diagnosed by 
diabetes according to American Diabetes Association (2014a) criteria were selected by a 
random sampling method. The aim of this study was to evaluate the glycaemic control of 
diabetic patients. This study found that 90% of patients were older than 40 years old and 
90% of them were obese. 60% of patients had fasting blood glucose at more than 7.2 
mmol/L and only 40% of patients had achieved the optimal glycaemic control of <7%. 
Triglyceride levels were normal in only 56% of the patients, while 50% had uncontrolled 
BP. Finally, there was a significant relationship between HbA1c and age, sex and 
nationality, in which male, older patients and Saudi nationals had better glycaemic control 
(Al-Rowais, 2013). 
Akbar (2001b) conducted a cross-sectional study of 404 diabetic patients attending King 
Abdulaziz University Hospital medical clinic from June 1998 to July 2000 to determine 
the percentage of patients reaching target levels of glycaemic control, blood pressure and 
serum lipids. This study found that it is more difficult for females to achieve better 
glycaemic control, the target level of blood pressure, appropriate body mass index and low 
density lipoprotein than males for both Saudi and non-Saudi participants and 
recommended that greater effort is needed from both healthcare provider and patients to 
improve diet habits and drugs compliance in order to reduce the incidence of risk factors. 
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Finally, a longitudinal observational study was conducted in San Diego, California with 
type 2 diabetes patients from the Dulce project, a nurse-based diabetes management 
system. This study aimed to demonstrate the association of glycaemic control with 
different characteristic variables of type 2 diabetes patients. The study found that longer 
duration of disease, younger patients, patients who used a combination therapy of oral 
hypoglycaemic agent and insulin, and high cholesterol level were all associated with poor 
glycaemic control (Benoit, Fleming, Philis-Tsimikas, & Ji, 2005).     
 
2.1.7.1     Factors associated with glycaemic control 
Poor glycaemic control among type 2 diabetics is considered a major health problem and 
one of the risk factors for the development of different diabetes complications. Koro, 
Bowlin, Bourgeois, and Fedder (2004) showed that in order to prevent damage to organs 
and subsequent complications which can arise from diabetes, patients need to attain 
optimal glycaemic control, which constitutes the major therapeutic goal of healthcare 
management. Identifying demographic, clinical and psychological characteristics that 
predict poor glycaemic control may help to improve outcomes by provision of better 
intervention, which is appropriate for diabetic patients. From published literature, many 
factors have been found to be associated with poor glycaemic control among type 2 
diabetes sufferers. Many previous studies have reported that patients of a younger age, 
with a higher body mass index (BMI), longer duration of diabetes, and undergoing a 
combination therapy of an oral hypoglycaemic agent and insulin are associated with a 
higher level of HbA1c (Benoit et al., 2005; El-Kebbi et al., 2003; Nichols, Hillier, Javor, 
& Brown, 2000; Nyunt, Howteerakul, Suwannapong, & Rajatanun, 2010; Sanal, Nair, & 
